---
title: "IX生物制藥 (42C.SG) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/42C.SG/norm.md"
symbol: "42C.SG"
name: "IX生物制藥"
parent: "https://longbridge.com/zh-HK/quote/42C.SG.md"
datetime: "2026-05-12T17:47:31.564Z"
locales:
  - [en](https://longbridge.com/en/quote/42C.SG/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/42C.SG/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/42C.SG/norm.md)
---

# IX生物制藥 (42C.SG) — 財務報表

## 損益表 (SGD)

| 指標 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0009 | -0.0012 | -0.0012 | -0.0022 | -0.0022 |
| ROE | -34.67% | -99.47% | -182.80% | -2132.05% | -401.24% |
| 營業收入 | 1.59M | 1.59M | 1.59M | 2.03M | 2.03M |
| 凈利潤 | -916000.00 | -1.03M | -1.03M | -1.95M | -1.95M |
| 營業利潤 | -1.87M | -1.53M | -1.53M | -1.34M | -1.34M |
| 毛利率 | 38.14% | 25.73% | 25.73% | 29.87% | 29.87% |
| 凈利率 | -57.65% | -64.76% | -64.76% | -95.98% | -95.98% |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (SGD)

| 指標 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 27.36M | 15.89M | 15.89M | 11.28M | 11.28M |
| 權益乘數 | 1.61 | 3.84 | 3.84 | 30.92 | 30.92 |
| 每股凈資產 | 0.0167 | 0.0043 | 0.0043 | 0.0004 | 0.0004 |
| 資產周轉率 | 0.3623 | 0.4991 | 0.5176 | 0.5996 | 0.5700 |
| 現金及短投 | 16.49M | 5.77M | 5.77M | 935000.00 | 935000.00 |
| 存貨與應收 | 974000.00 | 881000.00 | 881000.00 | 922000.00 | 922000.00 |
| 長期投資 | 7.09M | 7.07M | 7.07M | 6.72M | 6.72M |
| 凈債務 | -10.59M | 966000.00 | 966000.00 | 4.97M | 4.97M |

## 現金流量表 (SGD)

| 指標 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -2.93M | -970500.00 | -970500.00 | -894500.00 | -894500.00 |
| 投資現金流 | -26000.00 | -1500.00 | -1500.00 | -39500.00 | -39500.00 |
| 融資現金流 | 13.67M | 3.42M | 3.42M | 337000.00 | 337000.00 |
| 自由現金流 | -2.27M | -776938.00 | -38938.00 | -667125.00 | -3125.00 |
| 現金流充裕率 | -328.59% | -527.45% | -527.45% | -317.20% | -317.20% |
| 舉債與償債 | 0.0000 | 271500.00 | 271500.00 | 754000.00 | 754000.00 |
| 資本支出 | -26000.00 | -1500.00 | -1500.00 | -39500.00 | -39500.00 |